Catalog No.
Product Name
Application
Product Information
Citations
-
Antibiotic
Iboxamycin is a potent antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. This compound demonstrates efficacy against both Gram-positive and Gram-negative bacterial infections, making it a valuable tool for research in microbiology. Its oral bioavailability and safety profile provide significant utility in in vivo studies, particularly in murine models. -
Antibiotic
2'-Amino-2'-deoxyguanosine is a nucleoside antibiotic that targets bacterial replication. It demonstrates lethal activity against specific strains of Escherichia coli, with its antibacterial effects reversible by guanosine and other purine nucleosides. This compound is suitable for studying bacterial infections and understanding the mechanisms of antibiotic resistance. -
Antibiotic
Amythiamicin C is an antimicrobial antibiotic that primarily targets Gram-positive bacteria, including strains of methicillin-resistant Staphylococcus aureus (MRSA). Additionally, it exhibits activity against Plasmodium falciparum, making it valuable for research in infectious diseases and antibiotic resistance. This compound is relevant for studies focused on the development of novel therapeutic strategies against resistant bacterial infections and malaria. -
Antibiotic
A51493A is an anthracyclinone antibiotic that exhibits potent antimicrobial activity against Gram-positive bacteria. This compound is useful in research applications focused on bacterial infections and exploring mechanisms of antibiotic resistance. Its unique structure and mode of action make it a valuable tool for studying antimicrobial efficacy and developing new therapeutic strategies. -
Antibiotic
Seldomycin factor 1 is an aminoglycoside antibiotic that targets bacterial protein synthesis. It exhibits a broad spectrum of antimicrobial activity against various Gram-positive and Gram-negative bacteria. This compound is valuable for research applications in microbiology and antibiotic resistance studies. -
Antibiotic
Chitinovorin C is a β-lactam antibiotic that primarily targets bacterial cell wall synthesis. It exhibits selective inhibitory activity against Gram-negative bacteria, making it a valuable tool in antibiotic research. This compound is utilized in studies aimed at understanding antibiotic resistance mechanisms and developing new therapeutic strategies against bacterial infections. -
Antibiotic
Spectinomycin sulfate hydrate is an antibiotic that primarily targets bacterial ribosomes to inhibit protein synthesis. It demonstrates broad-spectrum activity against various gram-positive and gram-negative organisms, making it a valuable tool in microbiological research. Additionally, Spectinomycin sulfate hydrate acts as a noncompetitive inhibitor of td intron RNA, with a reported Ki value of 7.2 mM, further expanding its utility in molecular biology studies. -
Antibiotic
Parvodicin B1 is a glycopeptide antibiotic that exerts its antimicrobial effects by inhibiting bacterial cell wall synthesis. It demonstrates significant activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. Parvodicin B1 is valuable in microbiological research and antibiotic susceptibility studies, providing insights into bacterial resistance mechanisms and antibiotic efficacy. -
Antibiotic
Sch 29482 is an orally active penem antibiotic that exhibits broad-spectrum antibacterial activity. This compound demonstrates effectiveness against a variety of Gram-positive and Gram-negative bacteria, making it a valuable tool for research into antibacterial treatments. Its unique mechanism of action interferes with bacterial cell wall synthesis, providing insights into antibiotic efficacy and resistance mechanisms. -
Antibiotic
Methacycline is a tetracycline antibiotic that primarily inhibits bacterial protein synthesis. It is recognized for its capacity to impede epithelial-to-mesenchymal transition (EMT) in vitro and to inhibit fibrogenesis in vivo, functioning independently of TGF-β1 Smad signaling pathways. Methacycline serves as an antimicrobial agent and demonstrates potential applications in the study of pulmonary fibrosis. -
Antibiotic
Pristinamycin II B is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable reagent in studies focused on the treatment of infections caused by resistant strains. This compound is commonly utilized in research applications related to antibiotic resistance and the development of novel antimicrobial therapies. -
Antibiotic
Helvolinic acid is a steroidal antibiotic that targets Gram-positive bacteria. This compound exhibits significant antibacterial activity, making it a valuable tool in the study of antimicrobial mechanisms and the development of new therapeutic agents. Its efficacy against resistant strains of bacteria positions it as a noteworthy reagent in antibiotic research and development. -
Antitumor Antibiotic
Menoxymycin B is an antitumor antibiotic that exhibits notable cytotoxic effects against cancer cells. It demonstrates potent inhibitory activity with IC50 values of 0.22 μM in KB cells and 0.023 μM in N18-RE-105 cells. This compound is valuable for cancer research, particularly in studies focused on cell proliferation and apoptosis mechanisms. -
Antibiotic
Minosaminomycin is an antibiotic that targets bacterial cells and is derived from the bacterium Streptomyces No. MA514A1. This compound demonstrates significant antimicrobial activity against Mycobacterium smegmatis ATCC 607 and Mycobacterium phlei, with minimum inhibitory concentrations (MIC) of 1.56 μg/mL and 6.25 μg/mL, respectively. Minosaminomycin is valuable for research applications focused on bacterial infections and the study of mycobacterial resistance. -
Antibiotic
Abbeymycin is an antibiotic derived from the actinobacterium Streptomyces sp. AB-999F-52, exhibiting potent antimicrobial activity primarily against anaerobic bacteria. Its specific action makes Abbeymycin a valuable tool in antibiotic discovery and screening research, aiding in the exploration of novel antimicrobial compounds. -
Antibiotic
Arylomycin B4 is a lipohexapeptide antibiotic specifically targeting Gram-positive bacteria. It demonstrates potent antimicrobial activity by inhibiting bacterial protein synthesis. This compound is valuable for research applications focused on the mechanisms of antibiotic resistance and the development of new antimicrobial agents. -
Antibiotic
Sapurimycin is an antitumor antibiotic derived from Streptomyces DO-116, belonging to the capramycin family. It demonstrates potent activity against Gram-positive bacteria and exhibits significant antitumor efficacy against leukemia P388 and sarcoma 180 in murine models. In vitro assays reveal that Sapurimycin induces single-strand breaks in supercoiled plasmid DNA, highlighting its potential utility in genomic studies and cancer research. -
Antibiotic
Cedarmycin A is an antibiotic with demonstrated efficacy against Candida species, Cryptococcus neoformans, and Aspergillus fumigatus, with minimum inhibitory concentration (MIC) values ranging from 12.5 to 50 μg/mL. It serves as a valuable research tool for investigating fungal infections and the development of antifungal therapies. Cedarmycin A's unique mechanism of action makes it an important compound for studying microbial resistance and host-pathogen interactions. -
Antitumor Antibiotic
Primocarcin is an antitumor antibiotic that specifically targets Ehrlich ascites carcinoma. Its mechanism of action involves the inhibition of tumor cell proliferation, making it a valuable compound for cancer research. Primocarcin is utilized in various studies aimed at understanding the efficacy of novel antitumor therapies and the biochemical pathways involved in cancer progression. -
Antibiotic
3''-Deamino-3''-hydroxykanamycin B is an antibiotic derived from the bacterium S. tenebrarius, specifically targeting bacterial ribosomes to inhibit protein synthesis. This compound exhibits notable effectiveness against Escherichia coli strains, including E. coli ATCC 25922 and E. coli CCARM 1A020, with minimum inhibitory concentration (MIC) values of 128 μg/mL. It is suitable for research applications involving antibiotic resistance and microbial susceptibility studies. -
Antibiotic
Eurocidin D is a cyclic peptide antibiotic that primarily targets and inhibits mast cell degranulation in rat models. This compound demonstrates significant anti-inflammatory properties, making it a valuable tool for studying allergic reactions and mast cell biology. Its unique mechanism of action positions it as a potential research candidate in understanding and treating conditions related to mast cell activation. -
Antibiotic
Lankacidinol is an antibiotic that exhibits significant biological activity against various pathogens. Its related metabolites, 2,18-seco-lankacidinol A and 2,18-seco-lankacidinol B, also demonstrate noteworthy medicinal properties. Notably, 2,18-seco-lankacidinol A has shown potent antitumor activity, making Lankacidinol a compound of interest for research in antibiotic and cancer therapeutics. -
Antibiotic
Oryzoxymycin is an aromatic derivative antibiotic targeting bacterial ribosomes to inhibit protein synthesis. This compound exhibits potent activity against Gram-negative bacteria, making it a valuable tool for studying antibiotic resistance mechanisms and bacterial infection pathways. It is applicable in research focused on microbial physiology and the development of new antibacterial agents. -
Antibiotic
BO-1165 is a potent antibiotic targeting Gram-negative bacteria with minimal efficacy against Gram-positive and anaerobic bacteria. It exhibits significant antibacterial activity against Pseudomonas aeruginosa, presenting a MIC50 of 3.12 mg/L, and against P. cepacia with a MIC50 of 1.56 mg/L. This compound is primarily utilized in research focused on combating infections caused by resistant Gram-negative pathogens. -
Antitumor Antibiotic
7-Hydroxyguanine is an antitumor antibiotic that primarily targets nucleic acid synthesis. It exhibits significant cytotoxicity against L1210 leukemia cells, effectively inhibiting their growth. This compound is utilized in cancer research to study mechanisms of action related to nucleobase analogs and their potential therapeutic applications. -
Antibiotic
Mikanolide is a sesquiterpene with notable antibacterial activity, primarily targeting Staphylococcus aureus. Demonstrating effective growth inhibition, it produces a zone of inhibition of 14 mm when tested at a concentration of 100 μg per disk. This compound may serve as a valuable tool in antibiotic research and the study of bacterial resistance mechanisms. -
Antibiotic
Dermadin is an antibiotic that targets bacterial infections through its antibacterial mechanisms. It exhibits significant antibacterial activity, making it suitable for research applications aimed at understanding and combating bacterial infections. This compound is particularly useful in studies focusing on antibiotic resistance and the development of new antimicrobial therapies. -
Antibiotic
Adenomycin is an antibiotic with a primary mechanism of action targeting mycobacteria. It demonstrates significant antimicrobial activity against a broad spectrum of mycobacterial species, making it a valuable reagent in research focused on mycobacterial infections and antibiotic resistance. Its efficacy in inhibiting mycobacterial growth facilitates studies in microbiology and drug development. -
Antitumor Antibiotic
16-Methyloxazolomycin is an antitumor antibiotic that exhibits significant antibacterial and antifungal activity. It has demonstrated efficacy against leukemia P388 cells and human lung adenocarcinoma cells, making it a valuable tool for cancer research and therapeutic development. This compound is utilized in the study of tumor biology and the exploration of novel therapeutic approaches in oncology. -
Antibiotic
Fluvirucin B1 is an antibiotic primarily targeting the influenza A virus. It exhibits potent antiviral activity by inhibiting viral replication, making it a valuable tool for research on influenza pathogenesis and antiviral drug development. Its efficacy in combating influenza A can aid in exploring therapeutic interventions in related viral infections. -
Antibiotic
Espinomycin A3 is a sixteen-membered macrolide antibiotic that targets bacterial protein synthesis, specifically inhibiting peptide elongation. It exhibits potent activity against Gram-positive bacteria, making it a valuable tool for research in antimicrobial mechanisms and antibiotic resistance. This compound is useful for studies focused on discovering new treatments for bacterial infections. -
Antitumor Antibiotic
13-Hydroxyglucopiericidin A is an antitumor antibiotic that exhibits potent cytotoxic activity against various cancer cell lines. Its mechanism involves inhibiting key cellular processes essential for tumor growth and proliferation. This compound is valuable for research in cancer biology and the development of novel therapeutic strategies targeting tumor cells. -
Antibiotic
3,6-Dihydroxyindoxazene is an antibiotic that demonstrates selective activity against Gram-negative bacteria. Isolated from Chromobacterium violaceum, it serves as a valuable tool in the study of bacterial resistance and antibiotic efficacy. Its unique mechanism of action provides insights into the development of new antimicrobial strategies and treatments. -
Antibiotic
Glycothiohexide α is a peptide antibiotic that targets bacterial cell wall synthesis. It exhibits potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VREF), with minimum inhibitory concentration (MIC) values ranging from 0.03 to 0.06 μg/mL. This compound is valuable for research into antibiotic resistance and developing new therapeutic strategies against resistant infections. -
Antibiotic
Lenapenem, a carbapenem antibiotic, exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. This compound is utilized in research applications aimed at exploring bacterial resistance mechanisms and developing new antimicrobial strategies. Its efficacy against a broad spectrum of pathogens makes it a valuable tool for studying antibiotic pharmacodynamics and pharmacokinetics. -
Antibiotic
10'-Desmethoxystreptonigrin is an antibiotic that acts as an inhibitor of Ras Farnesyltransferase, exhibiting an IC50 of 21 μM. This compound demonstrates broad-spectrum antibacterial activity and shows antitumor effects against P388 leukemia, with an LD50 of 8.8 mg/kg indicating minimal cytotoxicity. It is a valuable reagent for research applications targeting antibiotic resistance and cancer therapeutics. -
Antibiotic
Acetylstachyflin is an antibiotic with demonstrated efficacy against Influenza A virus. Its primary mechanism involves targeting viral replication, thereby inhibiting the spread of the virus within host cells. This compound is valuable for research applications focused on antiviral drug development and understanding influenza pathogenesis. -
Antibiotic
Napyradiomycin B2 is an antibiotic that primarily targets Gram-positive bacteria and exhibits significant activity against mycobacteria. Its efficacy is limited against Gram-negative bacteria and fungi, making it a valuable compound for research into antimicrobial mechanisms and the development of new antibacterial agents. Napyradiomycin B2 is particularly relevant for studies investigating treatment options for infections caused by mycobacterial pathogens. -
Antibiotic
Saptomycin E is an antibiotic that exhibits antitumor properties by targeting and inhibiting bacterial protein synthesis. Its unique mechanism of action makes it a valuable tool for research in cancer biology and antibiotic development. This compound is effective in studying cell growth modulation and exploring therapeutic options against resistant bacterial strains. -
Antibiotic
Halomicin C is an ansamycin antibiotic that demonstrates antibacterial activity against both Gram-positive and Gram-negative bacteria. It serves as a valuable tool in microbiological research and the development of new antimicrobial agents, providing insights into bacterial resistance mechanisms and potential therapeutic applications. -
Antibiotic
Sannamycin G is an aminoglycoside antibiotic that exerts its activity primarily by inhibiting bacterial protein synthesis. While it demonstrates weak antibacterial activity against select bacterial strains, it serves as a valuable tool for research into antibiotic mechanisms and resistance. Its characterization can aid in the development of novel therapeutic strategies and the exploration of bacterial interactions. -
Antibiotic
Parvodicin C4 is a glycopeptide antibiotic that primarily targets bacterial cell wall synthesis. It demonstrates significant inhibitory activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. This compound is valuable for research applications focused on antibiotic resistance mechanisms and the development of new antimicrobial therapies. -
Antibiotic
11-Deoxy-13-dihydrodaunorubicin is an anthracycline antibiotic that primarily targets bacterial and tumor cells. It exhibits significant antibacterial activity against Gram-positive and negative bacteria, alongside notable antitumor properties. This compound is valuable for research applications in the fields of microbiology and oncology, particularly in the study of antibiotic resistance and cancer treatments. -
Antitumor Antibiotic
Miyakamide A2 is an antitumor antibiotic known for its insecticidal properties. It effectively inhibits the growth of Artemia salina and demonstrates moderate antixanthomonas activity. Additionally, Miyakamide A2 exhibits cytotoxic effects on P388 cancer cells, with an IC50 value of 12.2 μg/mL, making it applicable in cancer research and potential therapeutic development. -
Antibiotic
Deoxyfrenolicin is a quinone antibiotic that targets bacterial proliferation. Isolated from the fermentation broth of Streptomyces roseofulvus strain AM-3867, it belongs to the frenolicin class of antibiotics. Deoxyfrenolicin demonstrates significant antibacterial activity in vitro, effectively inhibiting the growth of Mycoplasma gallisepticum. This compound serves as a valuable tool for research applications in microbiology and antibiotic resistance studies. -
Antibiotic
Porothramycin B is an antibiotic that exhibits activity against Gram-positive and anaerobic bacteria. Its mechanism of action involves inhibiting bacterial protein synthesis, making it a valuable tool for studying bacterial infections. Researchers can utilize Porothramycin B in various microbiological applications, including the investigation of bacterial resistance mechanisms and the development of new therapeutic strategies. -
Antibiotic
Sakyomicin D is a benzoquinone antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antibacterial activity against Gram-positive bacteria. This compound is utilized in research focused on combating antibiotic resistance and exploring novel antibacterial mechanisms. Its unique structure and mechanism of action make it a valuable tool for studying microbial pathogenesis and the development of new therapeutic agents. -
Antibiotic
Dapdiamide A is an antibiotic that targets bacterial cell viability, derived from the Pantoea agglomerans CU0119 strain. It demonstrates significant antibacterial activity, making it a valuable compound for anti-infective research applications. This compound may contribute to the development of novel therapeutic strategies against bacterial infections. -
Antibiotic
Epihygromycin is a glycoside antibiotic primarily targeting bacterial ribosomes. It exhibits modest activity against Gram-positive bacteria, making it valuable for studies on antibiotic resistance and microbial bioassays. Its mechanism of action facilitates investigations into bacterial protein synthesis and the efficacy of antibiotic treatments. -
Antibiotic
Pyridindolol K2 is an alkaloid antibiotic derived from Streptomyces species K93-0711. It exhibits the ability to inhibit the adhesion of HL-60 cells, making it a valuable tool for studying cell adhesion mechanisms and potential therapeutic applications. This compound is of interest in the development of novel antibacterial agents and in various cancer research applications.
